It gives me great pleasure to announce a sponsor, Sanofi Diabetes.
For the 2016 Malvern Diabetic Foot Conference, Sanofi Diabetes will be sponsoring at the Gold level.
About Sanofi Diabetes
Sanofi is a global integrated healthcare leader focused on patients’ needs.
To meet the challenges facing the pharmaceutical industry, our strategy is based on the following key strategic priorities:
- Be a global healthcare leader with synergistic platforms
- Bring innovative products to market
- Seize value-enhancing growth opportunities
- Adapt our structure to future challenges and opportunities
Increasing innovation in Research & Development
By focusing on patient needs, we aim to become the most productive R&D organisation in healthcare. To this end, having completely reviewed our portfolio, we are evolving our decision-making process to create an innovative and dynamic culture, with a clear strategy for accessing the best science from around the world.
Adapting our structures to meet the challenges of the future
Recognising the need to change the industry model in order to generate more sustainable growth, and having identified the resources and capabilities required, we are active in markets as diverse as the patients themselves. New technologies open new avenues of research. Vaccines, biologics, branded generics and consumer healthcare products require a different approach, but we have a distinguished history of adapting to change and seizing new opportunities through innovation.
Exploring external growth opportunities
Diversification is essential to our future because the traditional small molecule medicines that constituted our core business are now vulnerable to patent expiry. While of course maintaining our valued presence in our traditional markets, we intend also to help meet future global healthcare challenges with a broader platform of offerings that are more affordable and accessible to patients, especially those with fewer economic resources.